MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1182/bloodadvances.2022007454

Медицинская библиотека · Blood advances · 2022

Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma.

Yamasaki-Morita Makiko, Arai Yasuyuki, Ishihara Takashi, Onishi Tomoko, Shimo Hanako, Nakanishi Kayoko, Nishiyama Yukiko, Jo Tomoyasu, Hiramatsu Hidefumi, Mitsuyoshi Takaya, Mizumoto Chisaki, Kanda Junya, Nishikori Momoko, Kitawaki Toshio, Nogami Keiji, Takaori-Kondo Akifumi, Nagao Miki, Adachi Souichi

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Anti-CD19 chimeric antigen receptor T (CAR-T) cell therapy has facilitated progress in treatment of refractory/relapsed diffuse large B-cell lymphoma (DLBCL). A well-known adverse event after CAR-T therapy is cytokine release syndrome(CRS). However, the etiology and pathophysiology of CRS-related coagulopathy remain unknown. Therefore, we conducted a prospective cohort study to comprehensively analyze coagulation/ fibrinolysis parameters present in peripheral blood of adult DLBCL patients treated with tisagenlecleucel in a single institution. Samples were collected from 25 patients at 3 time points: before lymphocyte-depletion chemotherapy and on days 3 and 13 after CAR-T infusion. After infusion, all patients except 1 experienced CRS, and 13 required the administration of tocilizumab. A significant elevation in the plasma level of total plasminogen activator inhibitor 1 (PAI-1), which promotes the initial step of coagulopathy (mean, 22.5 ng/mL before lymphocyte-depletion and 41.0 on day 3, P = .02), was observed at the onset of CRS. Moreover, this suppressed fibrinolysis-induced relatively hypercoagulable state was gradually resolved after CRS remission with normalization of total PAI-1 to preinfusion levels without any organ damage (mean values of soluble fibrin: 3.16 µg/mL at baseline, 8.04 on day 3, and 9.16 on day 13, P < .01; and mean PAI-1: 25.1 ng/mL on day 13). In conclusion, a hypofibrinolytic and relatively hypercoagulable state concomitant with significant total PAI-1 elevation was observed at the onset of CRS even in DLBCL patients with mild CRS. Our results will facilitate understanding of CRS-related coagulopathy, and they emphasize the importance of monitoring sequential coagulation/fibrinolysis parameters during CAR-T therapy.

Для цитирования: Yamasaki-Morita Makiko, Arai Yasuyuki, Ishihara Takashi, Onishi Tomoko, Shimo Hanako, Nakanishi Kayoko, Nishiyama Yukiko, Jo Tomoyasu, Hiramatsu Hidefumi, Mitsuyoshi Takaya, Mizumoto Chisaki, Kanda Junya, Nishikori Momoko, Kitawaki Toshio, Nogami Keiji, Takaori-Kondo Akifumi, Nagao Miki, Adachi Souichi. Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma.. Blood advances. 2022. DOI: 10.1182/bloodadvances.2022007454.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.